Copyright Reports & Markets. All rights reserved.

Global Paroxetine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Paroxetine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Paroxetine Hydrochloride Drug
      • 1.2.2 Paroxetine Mesylate Drug
    • 1.3 Market Analysis by Applications
      • 1.3.1 Depression
      • 1.3.2 Panic disorder
      • 1.3.3 Social anxiety disorder
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Apotex
      • 2.1.1 Business Overview
      • 2.1.2 Paroxetine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Apotex Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Sebela Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Paroxetine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sebela Pharmaceuticals Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Teva
      • 2.3.1 Business Overview
      • 2.3.2 Paroxetine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Teva Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Paroxetine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Sun Pharmaceutical
      • 2.5.1 Business Overview
      • 2.5.2 Paroxetine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sun Pharmaceutical Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Lupin
      • 2.6.1 Business Overview
      • 2.6.2 Paroxetine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Lupin Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Lannett Company
      • 2.7.1 Business Overview
      • 2.7.2 Paroxetine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Lannett Company Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Aurobindo
      • 2.8.1 Business Overview
      • 2.8.2 Paroxetine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Aurobindo Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Jubilant Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Paroxetine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Jubilant Pharma Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Sciecure Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Paroxetine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sciecure Pharma Paroxetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Paroxetine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Paroxetine Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Paroxetine Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Paroxetine Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Paroxetine Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Paroxetine Market Analysis by Regions

    • 4.1 Global Paroxetine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Paroxetine Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Paroxetine Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Paroxetine Sales and Growth Rate (2013-2018)
    • 4.3 Europe Paroxetine Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Paroxetine Sales and Growth Rate (2013-2018)
    • 4.5 South America Paroxetine Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Paroxetine Sales and Growth Rate (2013-2018)

    5 North America Paroxetine by Countries

    • 5.1 North America Paroxetine Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Paroxetine Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Paroxetine Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Paroxetine Sales and Growth Rate (2013-2018)
    • 5.3 Canada Paroxetine Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Paroxetine Sales and Growth Rate (2013-2018)

    6 Europe Paroxetine by Countries

    • 6.1 Europe Paroxetine Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Paroxetine Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Paroxetine Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Paroxetine Sales and Growth Rate (2013-2018)
    • 6.3 UK Paroxetine Sales and Growth Rate (2013-2018)
    • 6.4 France Paroxetine Sales and Growth Rate (2013-2018)
    • 6.5 Russia Paroxetine Sales and Growth Rate (2013-2018)
    • 6.6 Italy Paroxetine Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Paroxetine by Countries

    • 7.1 Asia-Pacific Paroxetine Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Paroxetine Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Paroxetine Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Paroxetine Sales and Growth Rate (2013-2018)
    • 7.3 Japan Paroxetine Sales and Growth Rate (2013-2018)
    • 7.4 Korea Paroxetine Sales and Growth Rate (2013-2018)
    • 7.5 India Paroxetine Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Paroxetine Sales and Growth Rate (2013-2018)

    8 South America Paroxetine by Countries

    • 8.1 South America Paroxetine Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Paroxetine Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Paroxetine Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Paroxetine Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Paroxetine Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Paroxetine Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Paroxetine by Countries

    • 9.1 Middle East and Africa Paroxetine Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Paroxetine Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Paroxetine Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Paroxetine Sales and Growth Rate (2013-2018)
    • 9.3 UAE Paroxetine Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Paroxetine Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Paroxetine Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Paroxetine Sales and Growth Rate (2013-2018)

    10 Global Paroxetine Market Segment by Type

    • 10.1 Global Paroxetine Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Paroxetine Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Paroxetine Revenue and Market Share by Type (2013-2018)
    • 10.2 Paroxetine Hydrochloride Drug Sales Growth and Price
      • 10.2.1 Global Paroxetine Hydrochloride Drug Sales Growth (2013-2018)
      • 10.2.2 Global Paroxetine Hydrochloride Drug Price (2013-2018)
    • 10.3 Paroxetine Mesylate Drug Sales Growth and Price
      • 10.3.1 Global Paroxetine Mesylate Drug Sales Growth (2013-2018)
      • 10.3.2 Global Paroxetine Mesylate Drug Price (2013-2018)

    11 Global Paroxetine Market Segment by Application

    • 11.1 Global Paroxetine Sales Market Share by Application (2013-2018)
    • 11.2 Depression Sales Growth (2013-2018)
    • 11.3 Panic disorder Sales Growth (2013-2018)
    • 11.4 Social anxiety disorder Sales Growth (2013-2018)
    • 11.5 Others Sales Growth (2013-2018)

    12 Paroxetine Market Forecast (2018-2023)

    • 12.1 Global Paroxetine Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Paroxetine Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Paroxetine Market Forecast (2018-2023)
      • 12.2.2 Europe Paroxetine Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Paroxetine Market Forecast (2018-2023)
      • 12.2.4 South America Paroxetine Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Paroxetine Market Forecast (2018-2023)
    • 12.3 Paroxetine Market Forecast by Type (2018-2023)
      • 12.3.1 Global Paroxetine Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Paroxetine Market Share Forecast by Type (2018-2023)
    • 12.4 Paroxetine Market Forecast by Application (2018-2023)
      • 12.4.1 Global Paroxetine Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Paroxetine Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Paroxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause.

      Scope of the Report:
      The worldwide market for Paroxetine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
      This report focuses on the Paroxetine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Apotex
      Sebela Pharmaceuticals
      Teva
      Mylan
      Sun Pharmaceutical
      Lupin
      Lannett Company
      Aurobindo
      Jubilant Pharma
      Sciecure Pharma

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Paroxetine Hydrochloride Drug
      Paroxetine Mesylate Drug

      Market Segment by Applications, can be divided into
      Depression
      Panic disorder
      Social anxiety disorder
      Others

      There are 15 Chapters to deeply display the global Paroxetine market.
      Chapter 1, to describe Paroxetine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Paroxetine, with sales, revenue, and price of Paroxetine, in 2016 and 2017;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Paroxetine, for each region, from 2013 to 2018;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
      Chapter 12, Paroxetine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
      Chapter 13, 14 and 15, to describe Paroxetine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

      Buy now